Potential Implications: The peptides ability to expedite the healing of incisional skin wounds opens up possibilities for therapeutic applications in wound management and recovery
Community reports consistently describe accelerated healing for acute soft tissue injuries, with noticeable improvement often occurring within 1-7 days
The selectivity of FOXO4-DRI depends on the differential expression of FOXO4 between senescent and non-senescent cells
Read review Dihexa for Endometriosis Brain Fog The November 2025 Lancet O&G/WH 'overlooked symptom' commentary from Edinburgh EXPPECT, the April 2025 Horn FACT-Cog 1,239-patient survey (~80% perceived cognitive impairment), the March 2025 NICE TA1057 Ryeqo approval (first daily pill on NHS), the April 2024 NICE NG73 update, the April 2026 renewed Womens Health Strategy with 117 action points, the 2023 Greaves CNS-wide glial activation mouse model, the BDNF/TrkB central-sensitisation directionality paradox, and the ~1.5 million UK women affected
The Bottom Line BPC-157 dosage depends on several factors, including your body weight, delivery method, and overall treatment goals
In the first vote, six peptide suppliers joined with a pharmaceutical executive and a compounding pharmacist to approve the peptide BPC-157 narrowly with an 8-6 vote